Iskra Pusic

Iskra Pusic

UNVERIFIED PROFILE

Are you Iskra Pusic?   Register this Author

Register author
Iskra Pusic

Iskra Pusic

Publications by authors named "Iskra Pusic"

Are you Iskra Pusic?   Register this Author

35Publications

1270Reads

48Profile Views

Engraftment of rare, pathogenic donor hematopoietic mutations in unrelated hematopoietic stem cell transplantation.

Sci Transl Med 2020 Jan;12(526)

Division of Hematology and Oncology, Department of Pediatrics, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO 63110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/scitranslmed.aax6249DOI Listing
January 2020

Ruxolitinib for steroid-refractory acute graft-versus-host disease.

Transpl Int 2019 Nov 21. Epub 2019 Nov 21.

Department of Medicine, Division of Oncology, Washington University School of Medicine in Saint Louis, Saint Louis, MO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tri.13560DOI Listing
November 2019

Ibrutinib for Chronic Graft-versus-Host Disease After Failure of Prior Therapy: 1-Year Update of a Phase 1b/2 Study.

Biol Blood Marrow Transplant 2019 Oct 28;25(10):2002-2007. Epub 2019 Jun 28.

Division of Hematology, Department of Internal Medicine, The Ohio State University Medical Center, Columbus, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.06.023DOI Listing
October 2019

The use of ruxolitinib for acute graft-versus-host disease developing after solid organ transplantation.

Am J Transplant 2019 Aug 25. Epub 2019 Aug 25.

Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajt.15579DOI Listing
August 2019

Association of Leukemia Cutis With Survival in Acute Myeloid Leukemia.

JAMA Dermatol 2019 Jul;155(7):826-832

Department of Medicine, Washington University School of Medicine in St Louis, St Louis, Missouri.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamadermatol.2019.0052DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6583862PMC
July 2019

Mutation Clearance after Transplantation for Myelodysplastic Syndrome.

N Engl J Med 2018 Sep;379(11):1028-1041

From the Department of Pathology and Immunology (E.J.D.), the Department of Medicine, Division of Oncology (M.A.J., C.A.M., N.E., J.S., K.E., J.R., S.E.H., K.B., L.D.W., M.J.C., I.P., J.S.W., G.L.U., D.C.L., J.F.D., P.W., T.J.L., M.J.W.), the McDonnell Genome Institute (G.S.C., C.A.M., H.A., R.S.F., C.C.F., M.O.), the Department of Medicine, Division of Hospital Medicine (R.S.), and Siteman Biostatistics Shared Resource, Siteman Cancer Center (K.T.), Washington University School of Medicine in St. Louis, St. Louis; and Massachusetts General Hospital Cancer Center, Boston (T.A.G.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1804714
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1804714DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6309244PMC
September 2018

TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes.

N Engl J Med 2016 11;375(21):2023-2036

the Department of Internal Medicine, Division of Oncology (J.S.W., L.D.W., G.L.U., A.G., M.H.T., I.P., R.R., T.A.F., K.E.S.-G., R.V., S.T.O., C.N.A., A.F.C., M.A.S., M.A.J., S.E.H., K.L., M.R.J., M.J.W., P.W., D.C.L., J.F.D., T.J.L.), and the Division of Biostatistics (J.D.B.), and the Department of Pathology and Immunology (E.J.D., B.T., Y.-S.L.), Washington University School of Medicine, and McDonnell Genome Institute, Washington University in St. Louis (A.A.P., C.A.M., C.C.F., M.O., R.S.F., R.K.W., L.D.W., T.J.L.) - both in St. Louis; the Departments of Internal Medicine (A.H., N.K., M.J.S., W.S.) and Pharmacy (R.W.K.), University of Chicago, Chicago; and the Department of Internal Medicine (T.A.G.), Massachusetts General Hospital, Boston.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1605949DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217532PMC
November 2016

Biomarker Panel for Chronic Graft-Versus-Host Disease.

J Clin Oncol 2016 08 23;34(22):2583-90. Epub 2016 May 23.

Jeffrey Yu, Kushi Kushekhar, Mohammad Abu Zaid, and Sophie Paczesny, Indiana University School of Medicine, Indianapolis, IN; Barry E. Storer, Paul J. Martin, Mary E. Flowers, John A. Hansen, Stephanie J. Lee, Qing Zhang, Philip R. Gafken, and Yuko Ogata, Fred Hutchinson Cancer Research Center; Barry E. Storer, University of Washington School of Medicine, Seattle, WA; Mukta Arora, University of Minnesota, Minneapolis, MN; Corey Cutler, Dana-Farber Cancer Institute, Boston, MA; Madan Jagasia, Vanderbilt University, Nashville, TN; Joseph Pidala, H. Lee Moffitt Cancer Center, Tampa, FL; Betty K. Hamilton, Cleveland Clinic Foundation, Cleveland, OH; George L. Chen, Roswell Park Cancer Institute, Buffalo, NY; and Iskra Pusic, Washington University School of Medicine, St Louis, MO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.9615DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012688PMC
August 2016

Peritransplant Serum Albumin Decline Predicts Subsequent Severe Acute Graft-versus-Host Disease after Mucotoxic Myeloablative Conditioning.

Biol Blood Marrow Transplant 2016 06 14;22(6):1137-1141. Epub 2016 Mar 14.

Bone Marrow Transplantation and Leukemia Section, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.03.010DOI Listing
June 2016

Glycoprotein YKL-40: a novel biomarker of chronic graft-vs-host disease activity and severity?

Croat Med J 2016 Jun;57(3):239-46

Nadira Duraković, University Hospital Centre Zagreb, Dept of Internal Medicine, Division of Hematology, Kišpatićeva 12, 10000 Zagreb, Croatia,

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937225PMC
http://dx.doi.org/10.3325/cmj.2016.57.239DOI Listing
June 2016

Economic evaluation of plerixafor for stem cell mobilization.

Am J Manag Care 2012 01;18(1):33-41

Center for Economic Evaluation in Medicine, Washington University School of Medicine, St. Louis, MO 63110-1093, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3650087PMC
January 2012

Update on clinical experience with AMD3100, an SDF-1/CXCL12-CXCR4 inhibitor, in mobilization of hematopoietic stem and progenitor cells.

Curr Opin Hematol 2010 Jul;17(4):319-26

Division of Oncology, Washington University School of Medicine, Siteman Cancer Center, St. Louis, MO 63110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOH.0b013e328338b7d5DOI Listing
July 2010